Warning letter
Gibson Laboratories Inc [ARCHIVED]: warning letter of Nov 3, 2009
FDA warning letter 82745 · Cincinnati District Office
Key facts
| Reference number | 82745 |
|---|---|
| Company | Gibson Laboratories Inc [ARCHIVED] |
| Subject | CGMP for Medical Devices/QS/Adulterated |
| Issue date | Nov 3, 2009 |
| Posted date | Nov 3, 2009 |
| Issuing office | Cincinnati District Office |
| Product type | Devices |
| CFR sections cited | 820, 803.17 |
| Inspection city | Lexington |
| Inspection ZIP | 40508 |
| Inspection start date | Aug 18, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: